Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum
Pei-Song Gao(Johns Hopkins University), Donald Y.M. Leung(Boston Children's Hospital), Nicholas Rafaels(Johns Hopkins University), Terri H. Beaty(Johns Hopkins University), Li Gao(Beijing Chao-Yang Hospital, Capital Medical University), Mark Boguniewicz(University of Colorado Denver), Tanda Murray(Johns Hopkins University), Lynda C. Schneider(Boston Children's Hospital), Lisa A. Beck(University of Rochester Medicine), Tissa Hata(University of California San Diego), Jon M. Hanifin(Oregon Health & Science University), Tracey Hand(Johns Hopkins University), Richard L. Gallo(University of California San Diego), Kathleen C. Barnes(Johns Hopkins University)
Cited by 245
Related Papers
The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know
|The Journal of Clinical Endocrinology & Metabolism|2010|4k
Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report
|Journal of Allergy and Clinical Immunology|2010|2.3k
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2.1k
Atopic dermatitis
|Nature Reviews Disease Primers|2018|1.5k
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
|New England Journal of Medicine|2014|1.4k